US4028379A - Process for preparing 2-amino-2-alkylthio-1-nitroethylene compounds - Google Patents
Process for preparing 2-amino-2-alkylthio-1-nitroethylene compounds Download PDFInfo
- Publication number
- US4028379A US4028379A US05/683,355 US68335576A US4028379A US 4028379 A US4028379 A US 4028379A US 68335576 A US68335576 A US 68335576A US 4028379 A US4028379 A US 4028379A
- Authority
- US
- United States
- Prior art keywords
- methylthio
- nitro
- ethylamino
- nitroethylene
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 17
- 150000001412 amines Chemical class 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 125000003545 alkoxy group Chemical group 0.000 claims description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims description 4
- -1 2-[(5-methyl-4-imidazolyl)methylthio]ethyl Chemical group 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 125000002883 imidazolyl group Chemical group 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 239000005864 Sulphur Substances 0.000 claims description 2
- 125000003282 alkyl amino group Chemical group 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 claims description 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 150000003852 triazoles Chemical class 0.000 claims description 2
- UGUHFDPGDQDVGX-UHFFFAOYSA-N 1,2,3-thiadiazole Chemical group C1=CSN=N1 UGUHFDPGDQDVGX-UHFFFAOYSA-N 0.000 claims 1
- 101150108015 STR6 gene Proteins 0.000 claims 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 abstract description 6
- 239000000543 intermediate Substances 0.000 abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- 239000000243 solution Substances 0.000 description 16
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- XTBZYMOXUSCADZ-UHFFFAOYSA-N 1-methylsulfanyl-1-methylsulfinyl-2-nitroethene Chemical group CSC(S(C)=O)=C[N+]([O-])=O XTBZYMOXUSCADZ-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000001953 recrystallisation Methods 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 3
- 229960001340 histamine Drugs 0.000 description 3
- DHXBCNRXZCWIBP-UHFFFAOYSA-N 1-n-methyl-1-n'-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethyl]-2-nitroethene-1,1-diamine Chemical group [O-][N+](=O)C=C(NC)NCCSCC=1NC=NC=1C DHXBCNRXZCWIBP-UHFFFAOYSA-N 0.000 description 2
- ARKLVGPFLIOWJI-UHFFFAOYSA-N 2,2,2-trifluoro-n-(1-methylsulfanyl-2-nitroethenyl)ethanamine Chemical group [O-][N+](=O)C=C(SC)NCC(F)(F)F ARKLVGPFLIOWJI-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- LEPBLJPGKGRXAD-UHFFFAOYSA-N n-(1-methylsulfanyl-2-nitroethenyl)-4-(1,3-thiazol-2-yl)butan-1-amine Chemical group [O-][N+](=O)C=C(SC)NCCCCC1=NC=CS1 LEPBLJPGKGRXAD-UHFFFAOYSA-N 0.000 description 2
- MSZPCNXIUQPHSY-UHFFFAOYSA-N n-[2-[(3-methoxypyridin-2-yl)methylsulfanyl]ethyl]-1-methylsulfanyl-2-nitroethenamine Chemical group COC1=CC=CN=C1CSCCNC(SC)=C[N+]([O-])=O MSZPCNXIUQPHSY-UHFFFAOYSA-N 0.000 description 2
- RCHLGFQVKQNCPN-UHFFFAOYSA-N n-ethyl-1-methylsulfanyl-2-nitroethenamine Chemical group CCNC(SC)=C[N+]([O-])=O RCHLGFQVKQNCPN-UHFFFAOYSA-N 0.000 description 2
- BDXCJNPWNAMQNB-UHFFFAOYSA-N n-methoxy-1-methylsulfanyl-2-nitroethenamine Chemical group CONC(SC)=C[N+]([O-])=O BDXCJNPWNAMQNB-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- YQFHPXZGXNYYLD-ARJAWSKDSA-N (z)-n-methyl-1-methylsulfanyl-2-nitroethenamine Chemical group CN\C(SC)=C\[N+]([O-])=O YQFHPXZGXNYYLD-ARJAWSKDSA-N 0.000 description 1
- NXGHEDHQXXXTTP-UHFFFAOYSA-N 1,1-bis(methylsulfanyl)-2-nitroethene Chemical group CSC(SC)=C[N+]([O-])=O NXGHEDHQXXXTTP-UHFFFAOYSA-N 0.000 description 1
- FRBQLQHVYSFABN-UHFFFAOYSA-N 1-N'-methoxy-1-N-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]-2-nitroethene-1,1-diamine Chemical group CONC(=C[N+]([O-])=O)NCCSCC=1N=CNC=1C FRBQLQHVYSFABN-UHFFFAOYSA-N 0.000 description 1
- BXXZRDXGIUACMP-UHFFFAOYSA-N 1-N-ethyl-1-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]-2-nitroethene-1,1-diamine Chemical group CCNC(=C[N+]([O-])=O)NCCSCC=1N=CNC=1C BXXZRDXGIUACMP-UHFFFAOYSA-N 0.000 description 1
- IHPJNPYNOZLKHE-UHFFFAOYSA-N 1-methylsulfanyl-2-nitro-n-[2-(1,2-oxazol-3-ylmethylsulfanyl)ethyl]ethenamine Chemical group [O-][N+](=O)C=C(SC)NCCSCC=1C=CON=1 IHPJNPYNOZLKHE-UHFFFAOYSA-N 0.000 description 1
- DKRMXXNYHKDNKY-UHFFFAOYSA-N 1-methylsulfanyl-2-nitro-n-[2-(1,2-thiazol-3-ylmethylsulfanyl)ethyl]ethenamine Chemical group [O-][N+](=O)C=C(SC)NCCSCC=1C=CSN=1 DKRMXXNYHKDNKY-UHFFFAOYSA-N 0.000 description 1
- AIAVBTROGNKBFP-UHFFFAOYSA-N 1-methylsulfanyl-2-nitro-n-[2-(1,3-thiazol-2-ylmethylsulfanyl)ethyl]ethenamine Chemical group [O-][N+](=O)C=C(SC)NCCSCC1=NC=CS1 AIAVBTROGNKBFP-UHFFFAOYSA-N 0.000 description 1
- SFBOFXWBLWSFSM-UHFFFAOYSA-N 1-n,1-n'-bis[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethyl]-2-nitroethene-1,1-diamine Chemical group N1=CNC(CSCCNC(NCCSCC2=C(N=CN2)C)=C[N+]([O-])=O)=C1C SFBOFXWBLWSFSM-UHFFFAOYSA-N 0.000 description 1
- WODCRFKQUCLRKR-UHFFFAOYSA-N 1-n-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethyl]-2-nitro-1-n'-(2,2,2-trifluoroethyl)ethene-1,1-diamine Chemical group CC=1N=CNC=1CSCCNC(NCC(F)(F)F)=C[N+]([O-])=O WODCRFKQUCLRKR-UHFFFAOYSA-N 0.000 description 1
- WFZLWBJWDHEACD-UHFFFAOYSA-N 1-n-methyl-2-nitro-1-n'-[2-(1,3-thiazol-2-ylmethylsulfanyl)ethyl]ethene-1,1-diamine Chemical group [O-][N+](=O)C=C(NC)NCCSCC1=NC=CS1 WFZLWBJWDHEACD-UHFFFAOYSA-N 0.000 description 1
- OZGGTQACSJTPFT-UHFFFAOYSA-N 1-n-methyl-2-nitro-1-n'-[4-(1,3-thiazol-2-yl)butyl]ethene-1,1-diamine Chemical group [O-][N+](=O)C=C(NC)NCCCCC1=NC=CS1 OZGGTQACSJTPFT-UHFFFAOYSA-N 0.000 description 1
- KIPSRYDSZQRPEA-UHFFFAOYSA-N 2,2,2-trifluoroethanamine Chemical compound NCC(F)(F)F KIPSRYDSZQRPEA-UHFFFAOYSA-N 0.000 description 1
- ZBHYOVVCRWKPHZ-UHFFFAOYSA-N 2-(1,2-oxazol-3-ylmethylsulfanyl)ethanamine Chemical compound NCCSCC=1C=CON=1 ZBHYOVVCRWKPHZ-UHFFFAOYSA-N 0.000 description 1
- GKIUPDRWOXMZDT-UHFFFAOYSA-N 2-(1,2-thiazol-3-ylmethylsulfanyl)ethanamine Chemical compound NCCSCC=1C=CSN=1 GKIUPDRWOXMZDT-UHFFFAOYSA-N 0.000 description 1
- QEBVWWWCJJNGRP-UHFFFAOYSA-N 2-(1,3,4-thiadiazol-2-ylmethylsulfanyl)ethanamine Chemical compound NCCSCC1=NN=CS1 QEBVWWWCJJNGRP-UHFFFAOYSA-N 0.000 description 1
- WAIHMWWSWLOHNH-UHFFFAOYSA-N 2-(1,3-thiazol-2-ylmethylsulfanyl)ethanamine Chemical compound NCCSCC1=NC=CS1 WAIHMWWSWLOHNH-UHFFFAOYSA-N 0.000 description 1
- BUTQLNVJGRJSAE-UHFFFAOYSA-N 2-(1h-1,2,4-triazol-5-ylmethylsulfanyl)ethanamine Chemical compound NCCSCC=1N=CNN=1 BUTQLNVJGRJSAE-UHFFFAOYSA-N 0.000 description 1
- YTFSLUOQGOXGNB-UHFFFAOYSA-N 2-(2-aminoethylsulfanylmethyl)pyridin-3-ol Chemical compound NCCSCC1=NC=CC=C1O YTFSLUOQGOXGNB-UHFFFAOYSA-N 0.000 description 1
- UMCHIQCDVOOJLO-UHFFFAOYSA-N 2-[(3-bromopyridin-2-yl)methylsulfanyl]ethanamine Chemical compound NCCSCC1=NC=CC=C1Br UMCHIQCDVOOJLO-UHFFFAOYSA-N 0.000 description 1
- HTABEAIBEITBJS-UHFFFAOYSA-N 2-[(3-chloropyridin-2-yl)methylsulfanyl]ethanamine Chemical compound NCCSCC1=NC=CC=C1Cl HTABEAIBEITBJS-UHFFFAOYSA-N 0.000 description 1
- VGMZAKKUIGITCD-UHFFFAOYSA-N 2-[(3-methoxypyridin-2-yl)methylsulfanyl]ethanamine Chemical compound COC1=CC=CN=C1CSCCN VGMZAKKUIGITCD-UHFFFAOYSA-N 0.000 description 1
- QCWHIZIEUXIMIM-UHFFFAOYSA-N 2-[(4-methyl-1,3-oxazol-5-yl)methylsulfanyl]ethanamine Chemical compound CC=1N=COC=1CSCCN QCWHIZIEUXIMIM-UHFFFAOYSA-N 0.000 description 1
- JEOZNMMOIBLWLV-UHFFFAOYSA-N 2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethanamine Chemical compound CC=1N=CNC=1CSCCN JEOZNMMOIBLWLV-UHFFFAOYSA-N 0.000 description 1
- XTYMVAZNONMQIS-UHFFFAOYSA-N 2-[2-[(1-methylsulfanyl-2-nitroethenyl)amino]ethylsulfanylmethyl]pyridin-3-ol Chemical group [O-][N+](=O)C=C(SC)NCCSCC1=NC=CC=C1O XTYMVAZNONMQIS-UHFFFAOYSA-N 0.000 description 1
- ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 description 1
- SYQVPTTZKGJDGY-UHFFFAOYSA-N 4-(1,3-thiazol-2-yl)butan-1-amine Chemical compound NCCCCC1=NC=CS1 SYQVPTTZKGJDGY-UHFFFAOYSA-N 0.000 description 1
- RWFMUTKWHQGNDU-UHFFFAOYSA-N 4-[(1-methylsulfanyl-2-nitroethenyl)amino]butan-1-ol Chemical group [O-][N+](=O)C=C(SC)NCCCCO RWFMUTKWHQGNDU-UHFFFAOYSA-N 0.000 description 1
- BLFRQYKZFKYQLO-UHFFFAOYSA-N 4-aminobutan-1-ol Chemical compound NCCCCO BLFRQYKZFKYQLO-UHFFFAOYSA-N 0.000 description 1
- 102000000543 Histamine Receptors Human genes 0.000 description 1
- 108010002059 Histamine Receptors Proteins 0.000 description 1
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
- ATTZFSUZZUNHBP-UHFFFAOYSA-N Piperonyl sulfoxide Chemical compound CCCCCCCCS(=O)C(C)CC1=CC=C2OCOC2=C1 ATTZFSUZZUNHBP-UHFFFAOYSA-N 0.000 description 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- RIMGDBZXWSGBQN-UHFFFAOYSA-N burimamide Chemical compound CNC(=S)NCCCCC1=CN=C[N]1 RIMGDBZXWSGBQN-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- NKDDWNXOKDWJAK-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC NKDDWNXOKDWJAK-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 1
- 229960000582 mepyramine Drugs 0.000 description 1
- KFIGICHILYTCJF-UHFFFAOYSA-N n'-methylethane-1,2-diamine Chemical compound CNCCN KFIGICHILYTCJF-UHFFFAOYSA-N 0.000 description 1
- UNXYQEPUQSDOJR-UHFFFAOYSA-N n-(2-methoxyethyl)-1-methylsulfanyl-2-nitroethenamine Chemical group COCCNC(SC)=C[N+]([O-])=O UNXYQEPUQSDOJR-UHFFFAOYSA-N 0.000 description 1
- UZRDXAFNFDWMBE-UHFFFAOYSA-N n-[2-[(3-bromopyridin-2-yl)methylsulfanyl]ethyl]-1-methylsulfanyl-2-nitroethenamine Chemical group [O-][N+](=O)C=C(SC)NCCSCC1=NC=CC=C1Br UZRDXAFNFDWMBE-UHFFFAOYSA-N 0.000 description 1
- RSNDFLSHLLKCMI-UHFFFAOYSA-N n-[2-[(3-chloropyridin-2-yl)methylsulfanyl]ethyl]-1-methylsulfanyl-2-nitroethenamine Chemical group [O-][N+](=O)C=C(SC)NCCSCC1=NC=CC=C1Cl RSNDFLSHLLKCMI-UHFFFAOYSA-N 0.000 description 1
- MVCKONDSKZNVRK-UHFFFAOYSA-N n-[2-[(5-methyl-1h-imidazol-4-yl)methylsulfanyl]ethyl]-1-methylsulfanyl-2-nitroethenamine Chemical group [O-][N+](=O)C=C(SC)NCCSCC=1NC=NC=1C MVCKONDSKZNVRK-UHFFFAOYSA-N 0.000 description 1
- YQFHPXZGXNYYLD-UHFFFAOYSA-N n-methyl-1-methylsulfanyl-2-nitroethenamine Chemical group CNC(SC)=C[N+]([O-])=O YQFHPXZGXNYYLD-UHFFFAOYSA-N 0.000 description 1
- BBGDJIVDZZTCFX-UHFFFAOYSA-N n-methyl-n'-(1-methylsulfanyl-2-nitroethenyl)ethane-1,2-diamine Chemical group CNCCNC(SC)=C[N+]([O-])=O BBGDJIVDZZTCFX-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 101150035983 str1 gene Proteins 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000004867 thiadiazoles Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
Definitions
- This invention relates to an improved process for the synthesis of amino compounds, in particular 2-amino-2-alkylthio-1-nitroethylenes and to the compounds so produced.
- Such a process is particularly useful for the production of certain compounds which are intermediates for the production of histamine H 2 -antagonists.
- a step in the process presently available for the production of many of these compounds involves the displacement of an alkylthio e.g., a methylthio group by an amino group and in certain cases, for example where the amine is not very reactive, this displacement may not take place easily. It is an object of the present invention to increase the efficiency of such displacement reactions.
- R 1 is lower alkyl, lower alkoxy, 2,2,2-trifluoroethyl, (CH 2 ) n R 2 or HetCH 2 Z(CH 2 ) 2 ;
- Het is an imidazole, thiazole, pyridine, isothiazole, oxazole, isoxazole, triazole or thiadiazole ring, which ring is optionally substituted by lower alkyl, hydroxyl, lower alkoxy, chlorine or bromine;
- Z is sulphur or methylene;
- n is an integer from 1 to 12; and
- R 2 is hydroxy, lower alkoxy or lower alkylamino.
- the compounds produced by the process of the present invention i.e., compounds of Formula III: ##STR2## are intermediates for the production of histamine H 2 - antagonists and may be converted to an H 2 -antagonist compound of Formula IV: ##STR3## by reaction thereof with an amine of formula R 3 NH 2 wherein R 3 is lower alkyl, lower alkoxy, 2,2,2-trifluoroethyl, (CH 2 ) n R 2 or HetCH 2 Z(CH 2 ) 2 but with the proviso that if R 1 is not HetCH 2 Z(CH 2 ) 2 then R 3 must be HetCH 2 Z(CH 2 ) 2 .
- lower alkyl we mean an alkyl group containing from 1 to 4 carbon atoms.
- the process of the present invention when carried out between equivalent amounts of the compounds of formulae I and II results in the production of the compound of Formula III without the formation of any significant amounts of the bis compound of Formula V: ##STR4## and this selectivity may in certain cases be desirable.
- the process of the invention may, in general, be carried out under mild conditions. For example gradual addition of a solution of the amine of Formula II to a stirred solution of the compound of Formula I at a temperature of from 15°-40° C. normally results in production of the required compound of Formula III which may then be isolated from the reaction mixture and purified by conventional methods. The reaction has been found to proceed successfully even when using amines which are normally comparatively unreactive e.g., those of Formula II wherein R is alkoxy or 2,2,2-trifluoroethyl.
- the compound of Formula I may be produced by treatment of the corresponding compound of Formula VI: ##STR5## wherein A has the above significance with an oxidizing agent such as hydrogen peroxide. This reaction may be carried out in a suitable solvent such as acetic acid.
- A is most conveniently methyl.
- the process is particularly useful for the production of compounds of Formula III wherein R 1 is alkoxy, (CH 2 ) n R 2 or Het CH 2 Z(CH 2 ) 2 .
- H 2 -antagonist compounds which are all intermediates for H 2 -antagonists, may be reacted with a suitable amine to yield H 2 -antagonist compounds such as:
- H 2 -antagonists of Formula IV act at histamine H 2 -receptors which as described by Black et al. (Nature, 1972, 236, 385) may be defined as those histamine receptors which are not blocked by "antihistamines" such as mepyramine but are blocked by burimamide. Blockade of histamine H 2 -receptors is of utility in inhibiting the biological actions of histamine which are not inhibited by "antihistamines”. Histamine H 2 -antagonists are useful, for example, as inhibitors of gastric acid secretion.
- Example 1 shows the preparation of a starting material.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB20628/75A GB1554153A (en) | 1975-05-15 | 1975-05-15 | Process for making 2-amino-2-alkylthionitroethylenes |
| UK20628/75 | 1975-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US4028379A true US4028379A (en) | 1977-06-07 |
Family
ID=10149067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US05/683,355 Expired - Lifetime US4028379A (en) | 1975-05-15 | 1976-05-05 | Process for preparing 2-amino-2-alkylthio-1-nitroethylene compounds |
Country Status (10)
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4169855A (en) * | 1976-08-04 | 1979-10-02 | Allen & Hansbury, Limited | N'-derivatives of n-(2-mercapto-ethyl)-2-nitro-1,1-ethenediamine |
| US4200760A (en) * | 1978-09-26 | 1980-04-29 | Bristol-Myers Company | Imidazolylalkylthioalkylamino-ethylene derivatives |
| EP0765870A3 (en) * | 1995-09-01 | 1998-06-17 | Rohm And Haas Company | Broad-spectrum antimicrobially active compounds |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA782129B (en) | 1977-04-20 | 1979-03-28 | Ici Ltd | Hertocyclic derivatives |
| US4165378A (en) | 1977-04-20 | 1979-08-21 | Ici Americas Inc. | Guanidine derivatives of imidazoles and thiazoles |
| EP0014057B1 (en) | 1979-01-18 | 1985-01-02 | Imperial Chemical Industries Plc | Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them |
| GB8415254D0 (en) * | 1984-06-15 | 1984-07-18 | Glaxo Group Ltd | Amine derivatives |
| DE3886467T2 (de) * | 1987-08-01 | 1994-06-01 | Takeda Chemical Industries Ltd | Alpha-ungesättigte Amine, ihre Herstellung und Verwendung. |
| GB8907700D0 (en) * | 1989-04-05 | 1989-05-17 | Fine Organics Ltd | Preparation of substituted ethenes |
| EP0396830B1 (en) * | 1989-05-10 | 1993-10-27 | Council of Scientific and Industrial Research | An improved process for the preparation of 1-substituted amino-1-substituted thio-2-nitro alkenes |
| FR3154258A1 (fr) | 2023-10-13 | 2025-04-18 | Psa Automobiles Sa | Dispositif de stockage d’energie pour une batterie a onduleur distribue comportant un circuit secondaire de by-pass |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3876647A (en) * | 1972-09-05 | 1975-04-08 | Smith Kline French Lab | Certain n-cyanoguanidines |
| GB1398426A (en) * | 1972-09-05 | 1975-06-18 | Smith Kline French Lab | Heterocyclic substituted guanidines |
| US3953460A (en) * | 1973-05-17 | 1976-04-27 | Smith Kline & French Laboratories Limited | Ethylene derivatives |
-
1975
- 1975-05-15 GB GB20628/75A patent/GB1554153A/en not_active Expired
-
1976
- 1976-04-21 ZA ZA762373A patent/ZA762373B/xx unknown
- 1976-04-26 IL IL49476A patent/IL49476A/xx unknown
- 1976-04-30 CA CA251,575A patent/CA1083159A/en not_active Expired
- 1976-05-05 US US05/683,355 patent/US4028379A/en not_active Expired - Lifetime
- 1976-05-06 BE BE166788A patent/BE841526A/xx not_active IP Right Cessation
- 1976-05-11 JP JP51053731A patent/JPS6058747B2/ja not_active Expired
- 1976-05-12 DE DE2621092A patent/DE2621092C2/de not_active Expired
- 1976-05-12 IE IE1012/76A patent/IE43687B1/en unknown
- 1976-05-14 FR FR7614612A patent/FR2311003A1/fr active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3876647A (en) * | 1972-09-05 | 1975-04-08 | Smith Kline French Lab | Certain n-cyanoguanidines |
| GB1398426A (en) * | 1972-09-05 | 1975-06-18 | Smith Kline French Lab | Heterocyclic substituted guanidines |
| US3953460A (en) * | 1973-05-17 | 1976-04-27 | Smith Kline & French Laboratories Limited | Ethylene derivatives |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4169855A (en) * | 1976-08-04 | 1979-10-02 | Allen & Hansbury, Limited | N'-derivatives of n-(2-mercapto-ethyl)-2-nitro-1,1-ethenediamine |
| US4200760A (en) * | 1978-09-26 | 1980-04-29 | Bristol-Myers Company | Imidazolylalkylthioalkylamino-ethylene derivatives |
| EP0765870A3 (en) * | 1995-09-01 | 1998-06-17 | Rohm And Haas Company | Broad-spectrum antimicrobially active compounds |
| US5883134A (en) * | 1995-09-01 | 1999-03-16 | Rohm And Haas Company | Broad-spectrum antimicrobially active compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| IE43687L (en) | 1976-11-15 |
| ZA762373B (en) | 1977-04-27 |
| JPS51141806A (en) | 1976-12-07 |
| JPS6058747B2 (ja) | 1985-12-21 |
| BE841526A (fr) | 1976-11-08 |
| IL49476A (en) | 1979-01-31 |
| DE2621092A1 (de) | 1976-11-25 |
| CA1083159A (en) | 1980-08-05 |
| IE43687B1 (en) | 1981-05-06 |
| FR2311003A1 (fr) | 1976-12-10 |
| GB1554153A (en) | 1979-10-17 |
| FR2311003B1 (enrdf_load_stackoverflow) | 1978-05-05 |
| IL49476A0 (en) | 1976-06-30 |
| DE2621092C2 (de) | 1986-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4028379A (en) | Process for preparing 2-amino-2-alkylthio-1-nitroethylene compounds | |
| SK281740B6 (sk) | Spôsob prípravy fluórfenikolu a jeho analógov | |
| IE44062B1 (en) | Thiourea guanidene and 1-nitro-2,2-diaminoethylene derivatives | |
| El-Wassimy et al. | The reaction of t-butyl hypochlorite with thiocarbonyl compound-a convenient method for the transformation | |
| SU814274A3 (ru) | Способ получени производныхАМидиНОМуРАВьиНОй КиСлОТы | |
| FR2557111A1 (fr) | Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent | |
| SU1072800A3 (ru) | Способ получени гидрогалогенидов 2-меркаптоэтиламина и его вариант | |
| EP0873327B1 (en) | Process for the preparation of 2-chloro-5-chloromethyl-thiazole | |
| EP0169688B1 (en) | Process for preparing anti-inflammatory cycloalkylidenemethylphenylacetic acid derivatives | |
| US3962272A (en) | 1h-tetrazole-1-acetate esters and acids and process therefor | |
| Outcalt | On the reaction of 2‐chloroethylisothiocyanate with aromatic amines | |
| CA1097374A (en) | 1-alkylsulphinyl-1-alkylthio-2-nitroethylenes | |
| US5103011A (en) | Preparation of 2-chloro-5- methyl-pyridine | |
| EP1651624B1 (en) | Process for the preparation of substituted thiazoles | |
| EP1311495B1 (en) | Catalytic process for the preparation of thiazole derivatives | |
| US4239895A (en) | Process for producing 1-hydroxymethylimidazoles | |
| EP0135803B1 (en) | Process for producing heterocyclic compounds having nitromethylene group as the side chain group | |
| EP0046635B1 (en) | Process for the preparation of cimetidine | |
| KR920010926B1 (ko) | 라니티딘 및 그의 히드로클로라이드의 제조방법 | |
| PL210124B1 (pl) | Sposób ciągłego wytwarzania pestycydów chlorotiazolowych | |
| US4166856A (en) | Thiazole and isothiazole derivative as blockers of histamine H2 -receptors | |
| US4665172A (en) | Process for producing heterocyclic compound having nitromethylene group as the side chain group | |
| US4658035A (en) | Preparation of 2-alkyl-4,5-dihydroxymethylimidazoles | |
| PL216068B1 (pl) | Sposób wytwarzania pochodnych tiazolu o dzialaniu pestycydowym | |
| US5910594A (en) | Process for the manufacture of 5-cyano-4-lower alkyl-oxazoles |